UTAH MEDICAL PRODUCTS INC (UTMD)

Surgical & Medical Instruments & Apparatus

Latest Price

$74.63

TTM P/E

22.75

Normalized P/E

18.24

Div Yield

Book Value

38.33

P/B Ratio

1.95

Valuation metrics

EPS: $3.48

Book value / share: $37.44

Formula: √(22.5 × EPS × BVPS)

Graham Number

$54.14

27% downside

Norm. op. income: $17M (median of 7yr)

Tax rate: 20%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$69.04

7% downside

Base FCF: $20M (median of recent 5yr)

Growth: 2%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$117.11

+57% upside

EPS: $3.48

Target P/E: 18×

Formula: EPS × P/E

P/E Fair Value

$62.64

16% downside

72.6% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BRANDES INVESTMENT PARTNERS, LP	475.2K	$32.0M	14.93%	+25.9K	2026-06-30
BlackRock, Inc.	203.7K	$14.0M	6.40%	+16.0K	2026-06-30
DIMENSIONAL FUND ADVISORS LP	198.8K	$13.0M	6.25%	+909	2026-06-30
RENAISSANCE TECHNOLOGIES LLC	175.8K	$12.0M	5.52%	-8.3K	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	134.5K	$9.0M	4.23%	-4.0K	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	108.0K	$7.0M	3.39%	-12.0K	2026-06-30
Minerva Advisors LLC	93.6K	$6.0M	2.94%	--	2026-06-30
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	85.2K	$5.0M	2.68%	-3.9K	2026-06-30
RICE HALL JAMES & ASSOCIATES, LLC	71.4K	$4.0M	2.24%	+3.5K	2026-06-30
MORGAN STANLEY	69.7K	$4.0M	2.19%	+20.9K	2026-06-30